PCI, CSP Technologies in Exclusive Activ-Blister Alliance

09.17.18

To provide clinical trials and stability testing utilizing Activ-Blister packaging solutions

PCI Pharma Services has entered an exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-Blister packaging solutions, which is designed to protect pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.  
 
CSP Technologies has developed several gas scavenging solutions to protect sensitive products. Activ-Blister solutions are designed to actively control the internal atmosphere/headspace of individual blister cavities without the use of purging, allowing for improved stability and enhanced shelf life. 
 
Using silica gel and molecular sieve technology, Activ-Blister solutions can absorb tailored amounts of moisture, oxygen and other gases, and can be produced in shapes and sizes to accommodate a variety of tablets or capsules. The technology can be applied without changes to the existing footprints of packaging lines, and can be incorporated into a wide range of blister packaging formats, including push-through blisters, peel/push blisters, cold-form foils and high barrier films containing Aclar laminates.